BIOTECH BY THE LAKE 2020

INVESTOR SUMMIT

Thursday, May 28, 2020

9:00 – 11:45 a.m. Central Time (CST)

(7:00 – 9:45 a.m. Pacific; 8:00 – 10:45 a.m. Mountain; 10:00 – 12:45 p.m. Eastern)

BIOTECH BY THE LAKE 2020 INVESTOR SUMMIT

 

The second Biotech by the Lake Investor Summit (now digital), hosted by the Chemistry of Life Processes Institute at Northwestern University, Oppenheimer & Co and BioCentury, will provide an exclusive look at next-generation cancer therapies and technologies. The program will feature Northwestern’s top innovators, investment experts, and biopharma industry leaders who will discuss latest developments, hottest trends in cancer research and investment opportunities within Chicago’s growing biotech community and beyond.
Attendees
Free and open to investment bankers, asset managers, corporate investors, early-stage venture investors, global biotech industry leaders, Northwestern faculty members and select guests

PROGRAM

NORTHWESTERN FACULTY PRESENTERS

9:00 a.m. (CST) - Welcome and Introduction

Thomas V. O’Halloran, PhD
Founding Director, Chemistry of Life Processes Institute
Charles E. and Emma H. Morrison Professor of Chemistry and Professor of Molecular Biosciences, Weinberg College of Arts & Sciences; Professor of Medicine, Feinberg School of Medicine

9:05 a.m. (CST) - Protein-Like Polymers: A Peptide Therapeutic Delivery Platform Technology

Nathan Gianneschi, PhD
Jacob and Rosaline Cohn Professor of Chemistry, Departments of Chemistry, Materials Science & Engineering, Biomedical Engineering and Pharmacology, Northwestern University

9:25 a.m. (CST) - Tissue Transglutaminase/Fibronectin Interaction, a Potential New Cancer Target

Daniela Matei, MD
Diana, Princess of Wales Professor of Cancer Research; Professor of Medicine (Hematology and Oncology) and Obstetrics and Gynecology, Feinberg School of Medicine

9:45 a.m. (CST) - Design-driven Engineering of Programmable Cell-based Therapies Through Synthetic Biology

Josh Leonard, PhD
Associate Professor of Chemical and Biological Engineering; Charles Deering McCormick Professor of Teaching Excellence, Northwestern University

PANEL DISCUSSION: HOT TOPICS IN CANCER THERAPEUTICS AND TECHNOLOGIES

10:05 a.m. (CST)

Moderator:
Simone Fishburn, PhD
VP & Editor in Chief, BioCentury Inc.

Panelist:
Andrew Chan, MD, PhD
Senior Vice President of Research Biology, Genentech

Panelist:
Elizabeth McNally, MD, PhD
Director, Center for Genetic Medicine; Elizabeth J. Ward Professor of Genetic Medicine; Professor of Medicine (Cardiology) and Biochemistry and Molecular Genetics, Northwestern Feinberg School of Medicine

Panelist:
Neil Kelleher, PhD
Walter and Mary E. Glass Professor of Molecular Biosciences; Professor of Chemistry; and Professor, Biochemistry and Molecular Genetics and Medicine, Faculty Director, Northwestern Proteomics

Panelist:
Nick Saccomano, PhD
CSO-SVP, Pfizer Boulder Research and Development

CORPORATE PRESENTERS:

10:25 a.m. (CST)

10:45 a.m. (CST)

11:05 (CST)

Jonathan Zalevsky, PhD
Chief Research and Development Officer, Nektar (NKTR)

PANEL DISCUSSION: FINANCING AND INVESTING IN ONCOLOGY BIOTECH

11:25 a.m.

Moderator:
Jay Olson, CFA
Research Analyst, Oppenheimer & Co.

Panelist:
Vanessa Bhark
Senior Associate, Frazier Healthcare Partners

Panelist:
Michael Margolis, R Ph
Managing Director, Oppenheimer & Co.

Panelist:
Alex Munns
Assistant Portfolio Manager, Driehaus Capital